Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details Textual)

v3.19.3
Organization and Nature of Operations (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 25, 2017
Oct. 19, 2016
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Organization and Nature of Operations (Textual)            
Ownership percentage     40.00%   40.00%  
Impairment loss     $ 1,010,011 $ 1,010,011
Avalon Healthcare System, Inc. [Member]            
Organization and Nature of Operations (Textual)            
Business acquired percentage   100.00%        
Exchange for common stock   50,000,000        
Percentage of capital stock   100.00%        
Ownership percentage     100.00%   100.00%  
GenExosome Technologies Inc. [Member]            
Organization and Nature of Operations (Textual)            
Acquired shares 600          
Consideration amount $ 1,326,087          
Common stock shares 500,000          
Ownership percentage     60.00%   60.00%  
Consideration of cash payment amount $ 450,000          
GenExosome Technologies Inc. [Member] | Asset Purchase Agreement [Member]            
Organization and Nature of Operations (Textual)            
Ownership percentage 60.00%          
Dr. Zhou [Member]            
Organization and Nature of Operations (Textual)            
Consideration amount $ 876,087          
Common stock shares 500,000          
Ownership percentage 40.00%          
Common stock issued 400